Medicare Enrolled

Dr. Ronan Kelly, MD

Internal Medicine · Dallas, TX
3410 WORTH ST STE 400, Dallas, TX 75246
2143701000
Registered in NPPES since 2011
NPI: 1477846715 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kelly from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kelly? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kelly

Dr. Ronan Kelly is an internal medicine specialist in Dallas, TX, with 15 years of NPI registration.

Between the years covered by Open Payments, Dr. Kelly received a total of $715,545 from 25 pharmaceutical and/or device companies across 379 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kelly is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 15 years of NPI registration $715,545 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$715,545
Total received (2018-2024)
Avg $102,221/year across 7 years
Top 0% in TX for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
25
Companies
379
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$249,614
2023
$152,060
2022
$61,973
2021
$169,231
2020
$36,428
2019
$18,713
2018
$27,526

Payments by company (2024)

E.R. Squibb & Sons, L.L.C.
$197,555
Astellas Pharma US Inc
$27,175
Daiichi Sankyo Inc.
$7,150
Merck Sharp & Dohme LLC
$4,295
AstraZeneca Pharmaceuticals LP
$3,842
Astellas Pharma Global Development
$3,419
BeiGene USA, Inc.
$3,375
AstraZeneca UK Limited
$2,569
Kite Pharma, Inc.
$170
Exact Sciences Corporation
$36
ABBVIE INC.
$28
Top 3 companies account for 92.9% of 2024 payments
All-time payments by company (2018-2024) ›
E.R. Squibb & Sons, L.L.C.
$463,625
Merck Sharp & Dohme Corporation
$47,746
Astellas Pharma US Inc
$40,766
AstraZeneca Pharmaceuticals LP
$31,928
Daiichi Sankyo Inc.
$21,781
Lilly USA, LLC
$14,965
EMD Serono, Inc.
$13,000
NOVARTIS PHARMACEUTICALS CORPORATION
$11,724
Merck Sharp & Dohme LLC
$8,565
Exact Sciences Corporation
$8,329
Novartis Pharmaceuticals Corporation
$7,122
Novocure Inc.
$6,742
Eli Lilly and Company
$6,595
Ipsen Biopharmaceuticals, Inc
$6,200
Takeda Pharmaceuticals U.S.A., Inc.
$5,610
AstraZeneca UK Limited
$4,526
Eisai Inc.
$4,080
Amgen Inc.
$3,430
Astellas Pharma Global Development
$3,419
BeiGene USA, Inc.
$3,375
US ENDOSCOPY
$1,725
Kite Pharma, Inc.
$170
Siemens Medical Solutions USA, Inc.
$79
ABBVIE INC.
$28
Pharmacyclics LLC, an AbbVie Company
$15
Top 3 companies account for 77.2% of all-time payments
Associated products mentioned in payments ›
ALUNBRIG · CYRAMZA · Cologuard Collection Kit · ENHERTU · EPKINLY · Enhertu · IMBRUVICA · KEYTRUDA · Lenvima · Molecular Accessories · Molecular Reagents/Test Kit/Clinical Utilization · ONIVYDE · OPDIVO · TABRECTA · TAGRISSO · TEVIMBRA · Tepmetko · Vyloy · YERVOY · ZYKADIA · truFreeze
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an internal medicine specialist in Dallas?
Compare internal medicine physicians in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians in nearby ZIP areas
2,123
County median income
$74,149
Nearest hospital to ZIP centroid (approximate)
BAYLOR UNIVERSITY MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment ✓ PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Kelly is an internal medicine specialist, with 15 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Kelly receive payments from pharmaceutical companies?
Yes. Dr. Kelly received a total of $715,545 from 25 companies across 379 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Kelly) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Same specialty & city
Internal Medicine Physicians in Dallas
Browse internal medicine physicians in Dallas ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in TX
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in TX
Which TX internal medicine physicians receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Merck Sharp & Dohme Corporation Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme Corporation.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →